Abstracts tagged "practice improvement and quality improvement"

Abstract Number: 95 • 2016 ACR/ARHP Annual Meeting
An Analysis of Malpractice Litigation in Rheumatology
Arpan Prabhu¹, Raghav Gupta², Ranjit Thomas³ and Chester V. Oddis⁴, ¹University of Pittsburgh School of Medicine, Pittsburgh, PA, ²Rutgers New Jersey Medical School, Newark, NJ, ³Tufts University, Medford, MA, ⁴Rheumatology/Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Medicine is an increasingly more litigious environment, and the probability of a practitioner facing a medical malpractice claim is high. Given the tumultuous liability…
Abstract Number: 996 • 2016 ACR/ARHP Annual Meeting
Use of a Shared Medical Appointment for Patients with Fibromyalgia in a Rural, Academic Medical Center: A Process Improvement Initiative for the Development of a New Care Model
Nicole M. Orzechowski¹, Debra Lloyd², Katherine Tuthill¹, Julie Puttgen³ and Rachael Bergeron¹, ¹Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, ³Dartmouth Hitchcock Medical Center, Lebanon, NH
Background/Purpose: Fibromyalgia is a complex chronic pain condition with patients often presenting with multiple somatic complaints that are difficult to address in standard new patient…
Abstract Number: 2484 • 2015 ACR/ARHP Annual Meeting
Use of Lean Six Sigma Methodology to Improve Time to Scheduling for New Patient Referrals to Rheumatology
Nicole Orzechowski¹, Mary Bolg², Rachael Bergeron¹, Christopher Dorman², Lauren Sanderson², Miranda Stark², Stacey Wilk² and Tammy Gray³, ¹Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²Dartmouth Hitchcock Medical Center, Lebanon, NH, ³White River Junction Family Practice, White River Junction, VT
Background/Purpose: Patient satisfaction is an important driver of patient-centered care. The Section of Rheumatology was taking on average 5 days to contact and schedule new…
Abstract Number: 1355 • 2014 ACR/ARHP Annual Meeting
Population Management of Rheumatoid Arthritis (RA) in Rheumatology Practices: A Quality Improvement Project
David Sikes¹, Gary Crump², Kathleen Thomas³, Alex Bangs⁴ and J. Timothy Harrington⁵, ¹Rheumatology, Florida Medical Clinic PA, Zephyrhills, FL, ²Rheumatology Associates - Louisville, Louisville, KY, ³Community Rheumatology, Noblesville, IN, ⁴Crescendo Bioscience, Inc, South San Francisco, CA, ⁵Joiner Associates LLC, Madison, WI
Background/Purpose: Population management (PM) is required for reducing the burdens of chronic diseases, including RA. PM depends on standardizing disease activity assessment (DAA) and coordinating…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].